OS Therapies Incorporated filed an amendment to a previous 8-K to include a side letter dated June 30, 2026, between the company and Leonite Fund I, LP. This letter was entered into as part of a private placement transaction and was inadvertently omitted from the original filing. The company operates in the medical technology industry, developing therapies for the treatment of various conditions.
